Kaukuntla Vandita

Kaukuntla Vandita

Active Director Director DIN 06396076
DIN 06396076 First appointment Oct 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Oct 2012
Shareholding value •••• Premium profile

About Kaukuntla Vandita

Data last updated:

Kaukuntla Vandita is a Director at Century Super Speciality Hospitals Private Limited (since 2024), Director at H V Medical Associates Private Limited (since 2012) and Designated Partner at Hvabode Greenscapes Vaibhav Habitats Llp (since 2025), and holds 1 more current directorship. The companies operate in Healthcare and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹49.06 Cr; the largest is Century Super Speciality Hospitals Private Limited at ₹49.06 Cr (FY 2025). Earlier, Kaukuntla Vandita was a Designated Partner at Hvabode Vaibhav Habitats Llp (2024).

DIN 06396076
Primary Designation Director
Industry Healthcare
First Appointment 26 Oct 2012
Oldest Company Age 14 yrs
Largest company Century Super Speciality Hospitals Private Limited · ₹49.06 Cr (FY 2025)
Combined revenue ₹49.06 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20242012₹49.06 Cr (FY 2025)Active
Director26 Oct 20122012₹21,966 (FY 2024)Active
Designated Partner27 Mar 20252025Active
Designated Partner03 Dec 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Feb 20242024Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
H V Medical Associates Private Limited
Hvabode Greenscapes Vaibhav Habitats Llp
Century Super Speciality Hospitals Private Limited
Hvabode Green Gardens Llp
Premium access

Shareholding and investment profile for Kaukuntla Vandita

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kaukuntla Vandita

Kaukuntla Vandita currently holds 4 directorships: Century Super Speciality Hospitals Private Limited (Director, since 10 May 2024, revenue ₹49.06 Cr (FY 2025)); H V Medical Associates Private Limited (Director, since 26 Oct 2012, revenue ₹21,966 (FY 2024)); Hvabode Greenscapes Vaibhav Habitats Llp (Designated Partner, since 27 Mar 2025); Hvabode Green Gardens Llp (Designated Partner, since 03 Dec 2024).

Kaukuntla Vandita was first appointed on 26 Oct 2012 as Director at H V Medical Associates Private Limited. The most recent appointment on record is 27 Mar 2025 at Hvabode Greenscapes Vaibhav Habitats Llp.

The 2 current companies of Kaukuntla Vandita that report revenue have a combined latest revenue of ₹49.06 Cr: Century Super Speciality Hospitals Private Limited ₹49.06 Cr (FY 2025); H V Medical Associates Private Limited ₹21,966 (FY 2024).

Kaukuntla Vandita held 1 earlier board appointment: Hvabode Vaibhav Habitats Llp (Designated Partner, 09 Feb 2024 to 03 Oct 2024).

The current boards of Kaukuntla Vandita's companies include Gangadhara Rao Iskala (Century Super Speciality Hospitals Private Limited), Hemanth Kumar Kaukuntla (Century Super Speciality Hospitals Private Limited), Hemanth Kumar Kaukuntla (Century Super Speciality Hospitals Private Limited), Kaukuntla Rithvik (Century Super Speciality Hospitals Private Limited), Kaukuntla Venugopal (Century Super Speciality Hospitals Private Limited), Megha Agarwal (Century Super Speciality Hospitals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available